Navigation Links
Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012
Date:4/4/2012

INDIANAPOLIS and ROLLING MEADOWS, Ill., April 4, 2012 /PRNewswire/ -- Lilly Diabetes today announced a donation of $100,000 to the Diabetes Scholars Foundation (Foundation) scholarship fund. The contribution will support the Foundation's mission to empower young people with type 1 diabetes to live their lives to the fullest. The Foundation will use the donation to fund college scholarships for students with type 1 diabetes as well as conference scholarships for families to attend the 2012 Children with Diabetes Friends for Life conference in Orlando. 

"We are committed to empowerment through education, and we are thrilled that Lilly Diabetes shares that commitment and is investing in the futures of young people with type 1 diabetes through this donation," said Mary Podjasek, president, Diabetes Scholars Foundation. "Life with diabetes is never easy. Our founders' goal was that – in this one small area of life – having diabetes could be an advantage."  

Supporting people with diabetes and their families through this donation is an example of Lilly Diabetes' commitment to providing personal solutions for everyday life. 

"In everything we do, we encourage people with diabetes to follow their dreams," said Steve Sugino, vice president, Lilly Diabetes. "It's a priority for us to support these amazing young people as they prove over and over again that diabetes doesn't stand in their way of achieving their goals."

College scholarship award criteria include community involvement, leadership, activities, and advocacy. Applicants must be incoming freshmen at an accredited college or university in the fall of 2012, must write an essay, and provide letters of recommendations from a physician treating their diabetes and a high school counselor/teacher. Applications, available online at www.diabetesscholars.org, are due May 15, 2012. Recipients will be announced by the Foundation in June.

Applications for conference scholarships for families to attend the 2012 Children with Diabetes Friends for Life Conference are also available online at www.diabetesscholars.org. Conference scholarship applications are due April 15, 2012, and recipients will be announced by the Foundation in May. 

For more information about the Foundation and its scholarship program, visit www.diabetesscholars.org. Additional information about Lilly Diabetes' patient support programs can be found at www.lillydiabetes.com.

About the Diabetes Scholars Foundation
In 2004, a group of parents who have children with type 1 diabetes created the Diabetes Scholars Foundation. Their goal was to lessen the burden of diabetes through education and give those affected by it tools they need to cope with the disease. Headquartered in Rolling Meadows, Ill, it is the only foundation that funds college scholarships open to all students in the United States with type 1 diabetes. In the past four years, the Foundation has awarded over $350,000 in college scholarships and over 200 Children with Diabetes Friends for Life conference scholarships. In 2011, the Foundation received over 500 college scholarship applications from 49 states. Information about the Foundation is available at www.diabetesscholars.org.

About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio and a continued commitment to providing real solutions–from medicines to support programs and more–to make lives better. For more information, visit www.lillydiabetes.com.

About Eli Lilly and Company (NYSE: LLY)
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers—through medicines and information—for some of the world's most urgent medical needs. Information about Lilly is available at www.lilly.com.

HI77345

P-LLY

(Logo: http://photos.prnewswire.com/prnh/20111111/DE03493LOGO )
(Logo: http://photos.prnewswire.com/prnh/20120404/DE81474LOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... -- Viverae ® , a leader in workplace wellness ... ® Watson Campaign Automation, implementing behavioral messaging within ... personalized experience. Through digital engagement, the platform prompts members ... time. The enhanced experience drives engagement by focusing on ... are in their journey to health. ...
(Date:4/18/2017)... DIEGO , April 18, 2017  Astute Medical, ... a case series to be presented at the 2017 ... which begins today and continues through April 22. Physicians ... IGFBP-7 , used to assess risk for acute kidney ... decompensated heart failure (ADHF). Elevated levels ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc. and ... started in 2016, in which Socionext extracts and ... The companies achieved initial results in reading ultrasound ... Artificial Brain SOINN. The results will be introduced ... April 19-21, at booths 4505 & 4507. ...
Breaking Medicine Technology:
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... choose a modern procedure that achieves results in a fraction of the time ... Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary treatment with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in ... to dispensaries and head shops –can’t help but be heartened by the industry’s current ... cannabis odor aptly described as “skunk smell.” At last they can simply, safely ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South ... special report in the May issue of Consumer Reports focused on heart health. ... results achieved during and after coronary bypass and aortic valve replacement procedures. , ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s ... bundles, which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use ...
(Date:4/24/2017)... ... April 24, 2017 , ... As part of the nationwide Days of Remembrance ... of the Holocaust and Nazi persecution, Center for Medicine after the Holocaust (CMATH) ... CMATH Champions trip to Germany and Poland next week. , The Fourth Biennial CMATH ...
Breaking Medicine News(10 mins):